What were KRM Ayurveda Ltd's latest quarterly results?
KRM Ayurveda Ltd's latest quarterly results (Mar 2026) show
- PAT Growth YoY: +140.0%
- Revenue Growth YoY: +29.3%
- Operating Margin: 33.0%
KRM Ayurveda Ltd: Stock Analysis & Fundamentals
Updated this weekKRM Ayurveda Ltd (Hospitals/Medical Services) — fundamental analysis, earnings data, and key metrics. PE: 27.0. ROE: 29.0%. This stock is not currently in the Nifty 500 momentum outperformers list.
KRM Ayurveda Ltd Key Facts
What's Happening
💪Debt reduced 100% YoY — balance sheet strengthening
Key Numbers
Current Price
₹255
Market Cap
543 Cr
Valuation
N/AOther Top Hospitals/Medical Services Stocks Beating Nifty 500
Frequently Asked Questions: KRM Ayurveda Ltd
Based on publicly available financial data. This is educational research, not investment advice.
What is KRM Ayurveda Ltd's current PE ratio?
KRM Ayurveda Ltd's current PE ratio is 27.0x.
- Current PE: 27.0x
- Market Cap: 543 Cr
What is KRM Ayurveda Ltd's price-to-book ratio?
KRM Ayurveda Ltd's price-to-book ratio is 4.7x.
- Price-to-Book (P/B): 4.7x
- Book Value per Share: ₹54
- Current Price: ₹255
Is KRM Ayurveda Ltd a fundamentally strong company?
KRM Ayurveda Ltd's fundamental strength based on key financial ratios
- Return on Capital (ROCE): 35.0%
Is KRM Ayurveda Ltd debt free?
KRM Ayurveda Ltd's debt position
- Total Debt: ₹0 Cr
What is KRM Ayurveda Ltd's return on equity (ROE) and ROCE?
KRM Ayurveda Ltd's return ratios over recent years
- FY2024: ROCE 22.0%
- FY2025: ROCE 42.0%
- FY2026: ROCE 35.0%
Is KRM Ayurveda Ltd's cash flow positive?
KRM Ayurveda Ltd's operating cash flow is positive (FY2026).
- Cash from Operations (CFO): ₹1 Cr
- Free Cash Flow (FCF): ₹-29 Cr
- CFO/PAT Ratio: 5% (weak cash conversion)
What is KRM Ayurveda Ltd's dividend yield?
KRM Ayurveda Ltd currently does not pay a significant dividend (yield 0.00%).
- Dividend Yield: 0.00%
- Current Price: ₹255
Who holds KRM Ayurveda Ltd shares — promoters, FII, DII?
KRM Ayurveda Ltd's shareholding pattern (Mar 2026)
- Promoters: 69.2%
- FII (Foreign): 3.9%
- DII (Domestic): 3.3%
- Public: 23.6%
Is KRM Ayurveda Ltd a new momentum entry or an established outperformer?
KRM Ayurveda Ltd is an established outperformer with 1 week of consecutive Nifty 500 outperformance.
Is KRM Ayurveda Ltd worth studying for long term investment?
Based on quantitative research signals, here is why KRM Ayurveda Ltd may be worth studying
- Cash flow is positive — CFO ₹1 Cr
What is the investment thesis for KRM Ayurveda Ltd?
KRM Ayurveda Ltd investment thesis summary:
What is the future outlook for KRM Ayurveda Ltd?
KRM Ayurveda Ltd's forward outlook based on current data signals
- Insufficient data for a forward assessment — monitoring for more signals
The above FAQs are generated from publicly available earnings data and conference call transcripts. This is educational research only. Sector Alpha is not SEBI registered and does not provide investment advice.